{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Wang Y"],"funding":["National University of Singapore","Singapore National Medical Research Council"],"pagination":["e2412677"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12079391"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(18)"],"pubmed_abstract":["Lipolysis of triglyceride-rich lipoproteins by peripheral lipoprotein lipase (LPL) plays an essential role in maintaining systemic cholesterol/lipid homeostasis. Human genetic studies have unequivocally demonstrated that activation of LPL pathway reduces risks for both coronary artery disease (CAD) and type 2 diabetes (T2D). Although sterol regulatory element-binding protein 2 (SREBP2) is well established as the master transcription factor that regulates the hepatic biosynthesis of both cholesterol and fatty acids, whether and how its activity in liver interacts with peripheral LPL pathway remains unknown. Here, it is demonstrated that acute liver-specific depletion of SREBP2 results in divergent effects on the regulation of peripheral LPL activity in mice, depending on the presence or abs"],"journal":["Advanced science (Weinheim, Baden-Wurttemberg, Germany)"],"pubmed_title":["Depletion of Hepatic SREBP2 Protects Against Hypercholesterolemia and Atherosclerosis through the ANGPTL3-LPL Axis."],"pmcid":["PMC12079391"],"funding_grant_id":["MOH-000896-00"],"pubmed_authors":["Choe JYS","Li H","Hu Y","Thi TT","Yu H","Shi Y","Liu Y","Cao X","Foo RSY","Cheng KY","Ji Y","Wang Y","Shen Y","Ackers-Johnson M"],"additional_accession":[]},"is_claimable":false,"name":"Depletion of Hepatic SREBP2 Protects Against Hypercholesterolemia and Atherosclerosis through the ANGPTL3-LPL Axis.","description":"Lipolysis of triglyceride-rich lipoproteins by peripheral lipoprotein lipase (LPL) plays an essential role in maintaining systemic cholesterol/lipid homeostasis. Human genetic studies have unequivocally demonstrated that activation of LPL pathway reduces risks for both coronary artery disease (CAD) and type 2 diabetes (T2D). Although sterol regulatory element-binding protein 2 (SREBP2) is well established as the master transcription factor that regulates the hepatic biosynthesis of both cholesterol and fatty acids, whether and how its activity in liver interacts with peripheral LPL pathway remains unknown. Here, it is demonstrated that acute liver-specific depletion of SREBP2 results in divergent effects on the regulation of peripheral LPL activity in mice, depending on the presence or abs","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 May","modification":"2026-06-03T02:46:43.404Z","creation":"2026-04-23T03:11:37.36Z"},"accession":"S-EPMC12079391","cross_references":{"pubmed":["40106311"],"doi":["10.1002/advs.202412677"]}}